{"filing":{"accession_number":"0001193125-26-288703","cik":"0001907108","ticker":"LXEO","company_name":"Lexeo Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-29","report_date":null,"primary_document":"lxeo-20260625.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526288703/lxeo-20260625.htm"},"events":[{"id":14734,"run_id":13125,"accession_number":"0001193125-26-288703","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a classic Item 5.07 disclosure reporting the results of the 2026 Annual Meeting of Stockholders held on June 25, 2026. The filing presents voting results for two proposals: (1) election of Class III Directors (R. Nolan Townsend, Brenda Cooperstone, and Paula HJ Cholmondeley) and (2) ratification of KPMG LLP as the independent auditor. The tabulated vote counts (FOR, WITHHELD/AGAINST, BROKER NON-VOTE/ABSTAIN) are the hallmark of shareholder vote result disclosures.","company_name":"Lexeo Therapeutics, Inc.","ticker":"LXEO","filing_date":"2026-06-29","form":"8-K","submitted_at":null,"items":[{"id":12253,"accession_number":"0001193125-26-288703","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of the 2026 Annual Meeting of Stockholders held on June 25, 2026. The filing presents voting results for two proposals: (1) election of Class III Directors (R. Nolan Townsend, Brenda Cooperstone, and Paula HJ Cholmondeley) and (2) ratification of KPMG LLP as the independent auditor. The tabulated vote counts (FOR, WITHHELD/AGAINST, BROKER NON-VOTE/ABSTAIN) are the hallmark of shareholder vote result disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T21:07:59.843095+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":12253,"accession_number":"0001193125-26-288703","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of the 2026 Annual Meeting of Stockholders held on June 25, 2026. The filing presents voting results for two proposals: (1) election of Class III Directors (R. Nolan Townsend, Brenda Cooperstone, and Paula HJ Cholmondeley) and (2) ratification of KPMG LLP as the independent auditor. The tabulated vote counts (FOR, WITHHELD/AGAINST, BROKER NON-VOTE/ABSTAIN) are the hallmark of shareholder vote result disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T21:07:59.843095+00:00","company_name":"Lexeo Therapeutics, Inc.","ticker":"LXEO","filing_date":"2026-06-29"}]}